SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BigKNY3 who wrote (3972)12/21/1997 7:02:00 AM
From: James Baker  Read Replies (1) of 23519
 
ooops BigKNY you have confused the Goldstein and Goldberg mentioned in the article. Still looking for Irwin Goldstein, MD. But even past contract does not tell the entire story. Look at Dr P-N he has worked for several ED companies since landmark NEJM article about MUSE - but now he has very little good to say about MUSE and the % successs fall with every interview. Have the studies changed or has the writer of his paycheck?????

<<<James: I always like a research challenge! Dr. Irwin Goldstein has
investigated MUSE.

In a 1997 issue of Medical Tribune (38 (3):1997) an article
"Understanding As Important As Treatment for Erectile Dysfunction"
featured an interview with Dr. Irwin Goldstein. It is noted that "Dr.
Goldberg, who participated in clinical trials of the device, said many
men prefer the MUSE to penile injections."

BigKNY3>>>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext